Is MRI Fusion Biopsy the New Gold Standard of Diagnosis? Con Argument
E. David Crawford, MD, argues that MRI fusion-guided biopsy should not be the gold standard of prostate cancer diagnosis. He cites MRI’s limitations in detecting clinically significant cancers and predicting extracapsular extension and tumor volume, as well as the existence of new technologies such as micro-ultrasound, in this point-counterpoint debate.
Read More